139 related articles for article (PubMed ID: 1376788)
1. Effects of intracoronary administration of endothelin in anesthetized dogs: comparison with Bay k 8644 and U 46619.
Hom GJ; Touhey B; Rubanyi GM
J Cardiovasc Pharmacol; 1992 Feb; 19(2):194-200. PubMed ID: 1376788
[TBL] [Abstract][Full Text] [Related]
2. Effects of intracoronary Bay k 8644, a calcium channel agonist, in anesthetized dogs.
Pelc LR; Gross GJ; Brooks HL; Warltier DC
J Cardiovasc Pharmacol; 1986; 8(6):1223-8. PubMed ID: 2434750
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of endothelin and Bay k 8644 on cardiohemodynamics in anesthetized pigs.
Adachi H; Shoji T; Goto K
Eur J Pharmacol; 1991 Jan; 193(1):57-65. PubMed ID: 1710988
[TBL] [Abstract][Full Text] [Related]
4. Influence of nifedipine, verapamil and diltiazem on pulmonary vascular resistance and vasoconstrictors in cats.
Erdemli O; Hao Q; Cai B; Lippton HL; Hyman A
Arch Int Pharmacodyn Ther; 1994; 328(2):165-79. PubMed ID: 7535994
[TBL] [Abstract][Full Text] [Related]
5. PCA50941, a new 1,4-dihydropyridine, reverses endothelin-induced cardiogenic shock in the anesthetized goat.
Fernández N; García JL; López MG; García AG; Diéguez G
Life Sci; 1998; 62(21):1933-42. PubMed ID: 9619842
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular mechanical consequences of dihydropyridine calcium channel modulation in conscious and anesthetized chronically instrumented dogs.
Pagel PS; Hettrick DA; Warltier DC
Anesthesiology; 1994 Jul; 81(1):190-208. PubMed ID: 7519000
[TBL] [Abstract][Full Text] [Related]
7. Calcium agonism, a new mechanism for positive inotropy. Hemodynamic effects and mode of action of BAY K 8644.
Schramm M; Towart R; Kazda S; Thomas G; Franckowiak G
Adv Myocardiol; 1985; 6():59-70. PubMed ID: 2581301
[TBL] [Abstract][Full Text] [Related]
8. Similarity and dissimilarity of the vasoconstrictor effects of Bay K 8644 on coronary, femoral, mesenteric and renal circulations of dogs.
Ishii K; Sato Y; Taira N
Br J Pharmacol; 1986 Jun; 88(2):369-77. PubMed ID: 2425879
[TBL] [Abstract][Full Text] [Related]
9. Effects of Bay k 8644 on the coronary vascular selectivity of the dihydropyridine Ca antagonists in the canine isolated, blood-perfused papillary muscle preparation.
Motomura S; Hashimoto K; Hashimoto K
J Cardiovasc Pharmacol; 1987 Dec; 10(6):627-35. PubMed ID: 2450231
[TBL] [Abstract][Full Text] [Related]
10. Different effects of mibefradil and amlodipine on coronary vessels and during beta-adrenergic stimulation in conscious dogs.
Heloire F; Hittinger L; Champagne S; Suto Y; Houel R; Ennezat PV; Sambin L; Crozatier B; Su JB
J Cardiovasc Pharmacol; 2002 Dec; 40(6):898-906. PubMed ID: 12451323
[TBL] [Abstract][Full Text] [Related]
11. Nisoldipine inhibits vasoconstrictor responses in the cat pulmonary vascular bed.
Kadowitz PJ; Lippton HL; Bellan JA; Hyman AL
J Appl Physiol (1985); 1989 Jun; 66(6):2885-90. PubMed ID: 2473060
[TBL] [Abstract][Full Text] [Related]
12. Coronary microvascular response to endothelin is dependent on vessel diameter and route of administration.
Lamping KG; Clothier JL; Eastham CL; Marcus ML
Am J Physiol; 1992 Sep; 263(3 Pt 2):H703-9. PubMed ID: 1415594
[TBL] [Abstract][Full Text] [Related]
13. Effects of the novel thromboxane antagonist Bay U 3405 on experimental coronary artery disease.
Fiedler VB; Seuter F; Perzborn E
Stroke; 1990 Dec; 21(12 Suppl):IV149-51. PubMed ID: 2260140
[TBL] [Abstract][Full Text] [Related]
14. Proarrhythmic activity of intracoronary endothelin in dogs: relation to the site of administration and to changes in regional flow.
Salvati P; Chierchia S; Dho L; Ferrario RG; Parenti P; Vicedomini G; Patrono C
J Cardiovasc Pharmacol; 1991 Jun; 17(6):1007-14. PubMed ID: 1714004
[TBL] [Abstract][Full Text] [Related]
15. Evidence for uneven distribution of L-type calcium channels in rat pulmonary circulation.
Walker BR
Am J Physiol; 1995 Dec; 269(6 Pt 2):H2051-6. PubMed ID: 8594916
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of Bay K 8644 and aortic constriction on regional myocardial blood flow and function in canine nonischemic and ischemic myocardium.
Thuillez C; Berdeaux A; Duhaze P; Bonhenry C; Giudicelli JF
J Cardiovasc Pharmacol; 1988 Mar; 11(3):344-53. PubMed ID: 2452929
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of LTC4 and TxA2 on coronary flow and myocardial function.
Nichols WW; Mehta JL; Thompson L; Donnelly WH
Am J Physiol; 1988 Jul; 255(1 Pt 2):H153-9. PubMed ID: 3394816
[TBL] [Abstract][Full Text] [Related]
18. Effect of endothelin on total and regional coronary resistance and on myocardial contractility.
Domenech R; Macho P; González R; Huidobro-Toro JP
Eur J Pharmacol; 1991 Jan; 192(3):409-16. PubMed ID: 2055239
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists.
Ashton JH; Schmitz JM; Campbell WB; Ogletree ML; Raheja S; Taylor AL; Fitzgerald C; Buja LM; Willerson JT
Circ Res; 1986 Nov; 59(5):568-78. PubMed ID: 3542279
[TBL] [Abstract][Full Text] [Related]
20. Positive inotropic actions of the calcium channel stimulator, Bay k 8644, in awake, unsedated dogs.
Preuss KC; Brooks HL; Gross GJ; Warltier DC
Basic Res Cardiol; 1985; 80(3):326-32. PubMed ID: 2411255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
